Neogen Corp (NEOG)

+20% growth, no debt, only 2 analysts looking at it and a market cap of under $200M. This is one of those small companies with lots of room to grow. Food safety and animal health testing are their core businesses, both of which have a great deal of potential upside these days.

Like most small companies, the stock price has not been steady. It has had its ups and downs, but if you plan to hold for a couple years or more, it should provide good price appreciation.

This is a nice, niche player in the health services industry, specializing in food safety. The recent earnings report was a blow-out, yet the company’s stock price has remained stagnant. What you’ve got here is a 25 percent grower with a sterling balance sheet and proven products that have yet to hit critical mass. A certain long-term outperformer!

undiscovered gem, no debt growing 15-21%, food testing products vital to processing, frugal, family style managment in a recession proof business

This company's market niche is estimated to be $1 billion. That's more than 10 times their current revenue levels. Once institutional investors discover the stock, it should have some good upside.

5-star $166 million market cap on 11/18/06
Food safety testing and animal safety.
5STARsmallCAPS picks five star stocks with the smallest market caps.

Lab diagnostics-you just can't go wrong here-relatively recession proof

Well run company with a nitch business id'g foods and animals for bacteria, toxins, allergens and diseses, plus sanitation concerns -- big issue in China's marketing of foods throughout the world.

No debt, long-term management who have a significant investment in the company.

Neogen is a well managed company that flys just under the radar of most Wall Street analysts. The analysts tend to follow IDEXX Labs as a proxy for this sector. I like Neogen here for its smaller size and flexibility. The company carries no debt and has healthy insider ownership. It also produces consistent results quarter to quarter and rarely disappoints.

Neogen has two separate, but related businesses. The first has to do with food safety testing for both humans and animals. This is obviously an area that has constant demand. The demand will accelerate as globalization makes it more difficult to follow food-borne disease. I wouldn't be surprised if the next administration beefs up the regulatory oversight responsibilities of the FDA and gets more serious about food safety, given recent panics over salmonella and such.

The second business involves the development and manufacture of a whole range of veteranary medicines and treatments. This is where Neogen unviels its biotech roots, but compounds and drugs developed for animals are approved much more easily than those for humans. I like the companies positioning, management, and balance sheet. Definitely a long term outperformer.

Continual, longer-term demand for food safety testing.
NEOG is small and has plenty or room to grow.

great company have owned the stock for 5 years.

This company always makes money and creates new products. It also did well when other stocks fell apart during the last recession. Why, because it always makes money. It is in a growing market and not widely followed.

The company has had 55 consecutive profitable quarters from operations and 59 quarters of the past 64 quarters with increased revenues when compared with the previous year.

Seems like a winner....

This animal and fodd safety products company is settling down after have a great run from mid 06 to the fall of 07. I lexpect this stock to take continue its upward move within the next couple months.

This is a pharmaceutical company/ biotechnology company that has been very consistent at growing the business without going out on a limb too far. They have make aquisitions and integrated them nicely into the company.

Small risk, but food safety will be important to people.

Should see long term gain.

bling bling

Member of the "Penny Stock Posse."

Recession proof industry!
Pretty good PE ratio! Go for it